RTRX - Retrophin Inc (Healthcare: Drug Manufacturers - Major) Projected Earnings Date: 2019-11-04    (Delayed quote data   2025-09-04)
Last
 21.15		 Change
 ⇑ +1.54   (+7.85%)		 Volume
  4,085,144
Open
 19.71		 High
 21.22		 Low
 19.46
8EMA (Daily)
 18.81		 40EMA (Daily)
 17.33		 50EMA (Daily)
 17.18		 STO (Daily)
 57.405		 MACD Hist (Daily)
 0.508
8EMA (Weekly)
 17.937		 40EMA (Weekly)
 16.76		 50EMA (Weekly)
 16.44		 STO (Weekly)
 68.019		 MACD Hist (Weekly)
 0.935
Company Profile
Retrophin Inc is a fully integrated biopharmaceutical company focused on the development, acquisition and commercialization of therapies for the treatment of serious, catastrophic or rare diseases.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com